Cardiovascular Working Party

The European Medicines Agency's (EMA) Cardiovascular Working Party (CVSWP) was set up by the Committee for Medicinal Products for Human Use (CHMP) to carry out specific tasks related to the cardiovascular system, diabetes and obesity.

The working party's tasks include:

• preparing, reviewing and updating guidelines and concept papers on working party related matters;
• European and international co-operation relating to working party activities;
• liaising with interested parties, such as industry, patient organisations and healthcare professional organisations;
• providing trainings and workshops to assessors;
• providing product related support upon request from EMA Committees and the Scientific Advice Working Party.

Mandate, rules of procedure and work programme

Mandate, objectives, and rules of procedure for working parties under the quality, non-clinical, methodology, clinical and veterinary domains

Reference Number: EMA/299541/2025

Consolidated 3-year rolling work plan for the Cardiovascular Working Party (CVSWP) 2025-2027

Reference Number: EMA/248684/2024

Composition

The working party is composed of five to nine experts from Member States, selected from the list of European experts and nominated by members of the CHMP. Experts are chosen on the basis of the best and available expertise needed for the working party to deliver its commitments.

The current members are listed below, in alphabetical order of surname. Their declarations of interests are available in the European experts list: 

• European experts

Members

• Kristina Dunder
• Antonio Gomez-Outes
• Alar Irs (Chair)
• Clemens Mittmann
• Gabriella Passacquale
• Jean-Michel Race
• Patrick Vrijlandt (Vice-Chair)